Will ONE Gas (OGS) Beat Estimates Again in Its Next Earnings Report?
This natural gas distribution has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 3.89%.
For the most recent quarter, ONE Gas was expected to post earnings of $1.98 per share, but it reported $1.85 per share instead, representing a surprise of 7.03%. For the previous quarter, the consensus estimate was $1.33 per share, while it actually produced $1.34 per share, a surprise of 0.75%.
Price and EPS Surprise
For ONE Gas, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
ONE Gas has an Earnings ESP of +4.76% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on August 5, 2025.
When the Earnings ESP comes up negative, investors should note that this will reduce the predictive power of the metric. But, a negative value is not indicative of a stock's earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ONE Gas, Inc. (OGS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Boeing (BA) To Report Earnings Tomorrow: Here Is What To Expect
Aerospace and defense company Boeing (NYSE:BA) will be reporting results this Tuesday before the bell. Here's what investors should know. Boeing missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $19.5 billion, up 17.7% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. Is Boeing a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Boeing's revenue to grow 28.5% year on year to $21.67 billion, a reversal from the 14.6% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$1.31 per share. Heading into earnings, analysts covering the company have mixed opinions about the business, with revenue estimates seeing 7 upward and 9 downward revisions over the last 30 days. Boeing has missed Wall Street's revenue estimates five times over the last two years. Looking at Boeing's peers in the aerospace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. AAR delivered year-on-year revenue growth of 14.9%, beating analysts' expectations by 8.6%, and Textron reported revenues up 5.4%, topping estimates by 2.4%. AAR traded up 13.4% following the results while Textron was down 8.9%. Read our full analysis of AAR's results here and Textron's results here. There has been positive sentiment among investors in the aerospace segment, with share prices up 6.8% on average over the last month. Boeing is up 11.3% during the same time and is heading into earnings with an average analyst price target of $240.08 (compared to the current share price of $233.27). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Bloomberg
an hour ago
- Bloomberg
BMW, Mercedes Dodge Trade Shock With €4 Billion Tariff Reprieve
By and Stefan Nicola Save BMW AG, Mercedes-Benz Group AG and other European automakers are getting a €4 billion ($4.7 billion) earnings lift from the trade deal the European Union struck with the US, according to Bloomberg Intelligence. European auto stocks rose on Monday over news that the rate on car imports from the EU would be lowered to 15% from 27.5%. BMW and Mercedes are also benefiting from tariff exemptions for about 185,000 cars they export annually from their American factories, BI analyst Michael Dean said in a note.
Yahoo
an hour ago
- Yahoo
Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating
Abbott Laboratories (NYSE:ABT) is one of the top low volatility healthcare stocks to buy now. Analyst Mike Kratky from Leerink Partners reiterated a Hold rating on Abbott Laboratories (NYSE:ABT) on July 21, decreasing the price target to $136.00 from $143.00. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The analyst justified the Hold rating with the company's performance, stating that Abbott Laboratories' (NYSE:ABT) recent Q2 earnings report presented a mixed picture. Management slashed their organic sales growth guidance, attributed primarily to several headwinds collectively affecting the Diagnostics segment outlook. These include changes in HIV funding, disruptions from value-based purchasing (VBP) in China, and weaker-than-expected COVID-19 sales. Kratky also stated that positive aspects for Abbott Laboratories (NYSE:ABT) exist amid these challenges, especially in the company's MedTech segment, which delivered solid growth. The non-MedTech segments are, however, continually facing complications, warranting a cautious outlook as these segments contribute significantly to the company's revenue. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare products. Its business segments include Diagnostic Products, Established Pharmaceutical Products, Medical Devices, and Nutritional Products. The company's Abbott Molecular is a leader in oncology molecular diagnostics with its Vysis FISH assays. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
